Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Vaxart Inc. (VXRT)

1.1   0.03 (2.8%) 02-14 16:00
Open: 1.14 Pre. Close: 1.07
High: 1.14 Low: 1.07
Volume: 3,716,201 Market Cap: 57M
Vaxart Inc, formerly known as Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.141 - 1.145 1.145 - 1.15
Low: 1.059 - 1.063 1.063 - 1.068
Close: 1.091 - 1.099 1.099 - 1.107

Technical analysis

as of: 2020-02-14 4:33:42 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 2.14     One year: 2.50
Support: Support1: 0.91    Support2: 0.34
Resistance: Resistance1: 1.83    Resistance2: 2.14
Pivot: 1.05
Moving Average: MA(5): 1.10     MA(20): 0.91
MA(100): 0.45     MA(250): 0.75
MACD: MACD(12,26): 0.18     Signal(9): 0.18
Stochastic oscillator: %K(14,3): 43.88     %D(3): 45.65
RSI: RSI(14): 59.98
52-week: High: 5.00  Low: 0.25  Change(%): -42.4
Average Vol(K): 3-Month: 608980  10-Days: 1618553

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
VXRT has closed below upper band by 44.3%. Bollinger Bands are 218.4% wider than normal. The large width of the bands suggest high volatility as compared to VXRT's normal range. The bands have been in this wide range for 17 bars. This is a sign that the current trend might continue.

Headline News

A Vaccine for Coronavirus? These 3 Healthcare Stocks Are Working on It
Fear and uncertainty have gripped the global population as the number of confirmed coronavirus cases grows daily. What started in Wuhan, the capital of China’s Hubei province, has now spread to 43,101 people in 25 different countries, according to the World Health Organization (WHO), killing over 1,000. While 75% of the infections have occurred in the Hubei province, a worldwide effort to contain the virus, now deemed as COVID-19 by WHO, is underway. These efforts include a two-day forum to create a “global research agenda” as well as quarantining individuals returning from the virus’ epicenter for 14 days, with the first 195 U.S. citizens under quarantine being released on February 11. The Centers for Disease Control and Prevention (CDC) has confirmed that 13 people in the U.S. have been infected, with the most recent case in San Diego after a repatriated individual that originally tested negative for the virus developed symptoms. As so much about COVID-19 remains unknown, it has become a race against the clock to find solutions.

Vaxart (VXRT) to Make Vaccines to Check Coronavirus, Stock Up
Vaxart (VXRT) begins a program to develop a vaccine candidate to counter the new coronavirus infection. Shares jump.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 47.72
Shares Float (M) 39.62
% Held by Insiders 1.54
% Held by Institutions 68.41
Shares Short (K) 492
Shares Short P. Month (K)

Stock Financials

EPS -1.510
Book Value (p.s.) 0.410
PEG Ratio
Profit Margin -222.20
Operating Margin -176.22
Return on Assets (ttm) -20.4
Return on Equity (ttm) -98.2
Qtrly Rev. Growth 61.6
Gross Profit (p.s.) -0.275
Sales Per Share
EBITDA (p.s.) -0.208
Qtrly Earnings Growth
Operating Cash Flow (M) -15.00
Levered Free Cash Flow (M) -7.62

Stock Valuations

P/E -0.73
P/E Growth Ratio 0.03
P/BV 2.68
P/S 1.61
P/CF -3.50

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date 2012-11-08
Forward Dividend
Last Split Date 2018-02-13
Last Split Ratio 0.091
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.